Yan Ming

CHIEF TECHNOLOGY OFFICER, DirectorCytek Biosciences, Inc. (CTKB) · full profile →Form 4 · filed Apr 11, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$13K
Net Open-Market Flow
-$13K
Transactions
2
2 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Apr 9, 2024Sell(S)400$7.01$3K6.0M
Apr 9, 2024Sell(S)2K$7.00$11K6.0M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-010714) within minutes of acceptance. Every field above traces to the original document. Verify it directly: